M D C Holdings Inc (MDC) Fundamental Analysis & Valuation

NYSE:MDC • US5526761086

62.98 USD
+0.03 (+0.05%)
At close: Apr 18, 2024
62.98 USD
0 (0%)
After Hours: 4/18/2024, 8:07:10 PM

This MDC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, MDC scores 6 out of 10 in our fundamental rating. MDC was compared to 60 industry peers in the Household Durables industry. Both the profitability and the financial health of MDC get a neutral evaluation. Nothing too spectacular is happening here. MDC has a decent growth rate and is not valued too expensively. Finally MDC also has an excellent dividend rating. This makes MDC very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

6

1. MDC Profitability Analysis

1.1 Basic Checks

  • In the past year MDC was profitable.
  • In the past year MDC had a positive cash flow from operations.
  • In the past 5 years MDC has always been profitable.
  • In multiple years MDC reported negative operating cash flow during the last 5 years.
MDC Yearly Net Income VS EBIT VS OCF VS FCFMDC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M

1.2 Ratios

  • MDC's Return On Assets of 7.08% is fine compared to the rest of the industry. MDC outperforms 62.69% of its industry peers.
  • MDC has a Return On Equity of 11.81%. This is comparable to the rest of the industry: MDC outperforms 56.72% of its industry peers.
  • MDC has a Return On Invested Capital (6.75%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for MDC is above the industry average of 9.04%.
  • The 3 year average ROIC (11.24%) for MDC is well above the current ROIC(6.75%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.08%
ROE 11.81%
ROIC 6.75%
ROA(3y)9.67%
ROA(5y)9.11%
ROE(3y)17.29%
ROE(5y)16.48%
ROIC(3y)11.24%
ROIC(5y)10.2%
MDC Yearly ROA, ROE, ROICMDC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

  • MDC has a better Profit Margin (8.59%) than 68.66% of its industry peers.
  • MDC's Profit Margin has improved in the last couple of years.
  • The Operating Margin of MDC (10.03%) is better than 61.19% of its industry peers.
  • MDC's Operating Margin has improved in the last couple of years.
  • MDC has a Gross Margin of 19.29%. This is amonst the worse of the industry: MDC underperforms 82.09% of its industry peers.
  • MDC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.03%
PM (TTM) 8.59%
GM 19.29%
OM growth 3Y-5.46%
OM growth 5Y1.73%
PM growth 3Y-2.84%
PM growth 5Y4.67%
GM growth 3Y-4.58%
GM growth 5Y-0.69%
MDC Yearly Profit, Operating, Gross MarginsMDC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

6

2. MDC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDC is creating some value.
  • Compared to 1 year ago, MDC has more shares outstanding
  • MDC has a better debt/assets ratio than last year.
MDC Yearly Shares OutstandingMDC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
MDC Yearly Total Debt VS Total AssetsMDC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

  • MDC has an Altman-Z score of 3.68. This indicates that MDC is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of MDC (3.68) is better than 62.69% of its industry peers.
  • MDC has a debt to FCF ratio of 3.28. This is a good value and a sign of high solvency as MDC would need 3.28 years to pay back of all of its debts.
  • MDC has a Debt to FCF ratio (3.28) which is comparable to the rest of the industry.
  • MDC has a Debt/Equity ratio of 0.50. This is a neutral value indicating MDC is somewhat dependend on debt financing.
  • MDC has a worse Debt to Equity ratio (0.50) than 61.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.28
Altman-Z 3.68
ROIC/WACC0.73
WACC9.28%
MDC Yearly LT Debt VS Equity VS FCFMDC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 7.70 indicates that MDC has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 7.70, MDC belongs to the top of the industry, outperforming 85.07% of the companies in the same industry.
  • A Quick Ratio of 2.69 indicates that MDC has no problem at all paying its short term obligations.
  • MDC's Quick ratio of 2.69 is amongst the best of the industry. MDC outperforms 92.54% of its industry peers.
Industry RankSector Rank
Current Ratio 7.7
Quick Ratio 2.69
MDC Yearly Current Assets VS Current LiabilitesMDC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

4

3. MDC Growth Analysis

3.1 Past

  • The earnings per share for MDC have decreased strongly by -31.16% in the last year.
  • The Earnings Per Share has been growing by 10.85% on average over the past years. This is quite good.
  • The Revenue for MDC has decreased by -18.80% in the past year. This is quite bad
  • The Revenue has been growing by 8.66% on average over the past years. This is quite good.
EPS 1Y (TTM)-31.16%
EPS 3Y0.91%
EPS 5Y10.85%
EPS Q2Q%44.44%
Revenue 1Y (TTM)-18.8%
Revenue growth 3Y5.97%
Revenue growth 5Y8.66%
Sales Q2Q%-11.39%

3.2 Future

  • MDC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.76% yearly.
  • The Revenue is expected to grow by 7.39% on average over the next years.
EPS Next Y-1.74%
EPS Next 2Y2.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.2%
Revenue Next 2Y7.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MDC Yearly Revenue VS EstimatesMDC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
MDC Yearly EPS VS EstimatesMDC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5

4. MDC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.93, which indicates a very decent valuation of MDC.
  • The rest of the industry has a similar Price/Earnings ratio as MDC.
  • MDC is valuated cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 12.14, which indicates a correct valuation of MDC.
  • MDC's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, MDC is valued rather cheaply.
Industry RankSector Rank
PE 11.93
Fwd PE 12.14
MDC Price Earnings VS Forward Price EarningsMDC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • MDC's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 68.66% of the companies in the same industry are more expensive than MDC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.12
EV/EBITDA 9.33
MDC Per share dataMDC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The decent profitability rating of MDC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.1
EPS Next 2Y2.76%
EPS Next 3YN/A

7

5. MDC Dividend Analysis

5.1 Amount

  • MDC has a Yearly Dividend Yield of 3.49%.
  • Compared to an average industry Dividend Yield of 1.19, MDC pays a better dividend. On top of this MDC pays more dividend than 88.06% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, MDC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.49%

5.2 History

  • The dividend of MDC is nicely growing with an annual growth rate of 15.41%!
  • MDC has paid a dividend for at least 10 years, which is a reliable track record.
  • As MDC did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)15.41%
Div Incr Years4
Div Non Decr Years6
MDC Yearly Dividends per shareMDC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

  • 38.93% of the earnings are spent on dividend by MDC. This is a low number and sustainable payout ratio.
  • MDC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP38.93%
EPS Next 2Y2.76%
EPS Next 3YN/A
MDC Yearly Income VS Free CF VS DividendMDC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M
MDC Dividend Payout.MDC Dividend Payout, showing the Payout Ratio.MDC Dividend Payout.PayoutRetained Earnings

MDC Fundamentals: All Metrics, Ratios and Statistics

M D C Holdings Inc

NYSE:MDC (4/18/2024, 8:07:10 PM)

After market: 62.98 0 (0%)

62.98

+0.03 (+0.05%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)04-25
Earnings (Next)07-25
Inst Owners26.27%
Inst Owner Change0%
Ins Owners0.23%
Ins Owner Change0%
Market Cap4.73B
Revenue(TTM)4.64B
Net Income(TTM)398.81M
Analysts48.33
Price Target58.14 (-7.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.49%
Yearly Dividend2.11
Dividend Growth(5Y)15.41%
DP38.93%
Div Incr Years4
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.26%
Min EPS beat(2)3.38%
Max EPS beat(2)15.13%
EPS beat(4)4
Avg EPS beat(4)44.26%
Min EPS beat(4)3.38%
Max EPS beat(4)93.72%
EPS beat(8)6
Avg EPS beat(8)17.75%
EPS beat(12)9
Avg EPS beat(12)12.15%
EPS beat(16)12
Avg EPS beat(16)14.32%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-2.9%
Max Revenue beat(2)3.41%
Revenue beat(4)3
Avg Revenue beat(4)9.71%
Min Revenue beat(4)-2.9%
Max Revenue beat(4)20.29%
Revenue beat(8)7
Avg Revenue beat(8)7.44%
Revenue beat(12)8
Avg Revenue beat(12)3.75%
Revenue beat(16)10
Avg Revenue beat(16)3.81%
PT rev (1m)-3.39%
PT rev (3m)8.37%
EPS NQ rev (1m)2.76%
EPS NQ rev (3m)9.52%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)8.96%
Revenue NQ rev (3m)12.73%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)1.36%
Valuation
Industry RankSector Rank
PE 11.93
Fwd PE 12.14
P/S 1.02
P/FCF 9.12
P/OCF 8.42
P/B 1.4
P/tB 1.4
EV/EBITDA 9.33
EPS(TTM)5.28
EY8.38%
EPS(NY)5.19
Fwd EY8.24%
FCF(TTM)6.91
FCFY10.97%
OCF(TTM)7.48
OCFY11.88%
SpS61.86
BVpS45.01
TBVpS44.93
PEG (NY)N/A
PEG (5Y)1.1
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.08%
ROE 11.81%
ROCE 9.36%
ROIC 6.75%
ROICexc 9.88%
ROICexgc 10.89%
OM 10.03%
PM (TTM) 8.59%
GM 19.29%
FCFM 11.17%
ROA(3y)9.67%
ROA(5y)9.11%
ROE(3y)17.29%
ROE(5y)16.48%
ROIC(3y)11.24%
ROIC(5y)10.2%
ROICexc(3y)13.75%
ROICexc(5y)12.3%
ROICexgc(3y)15.03%
ROICexgc(5y)13.54%
ROCE(3y)15.67%
ROCE(5y)14.28%
ROICexgc growth 3Y-6.21%
ROICexgc growth 5Y1.48%
ROICexc growth 3Y-5.69%
ROICexc growth 5Y1.3%
OM growth 3Y-5.46%
OM growth 5Y1.73%
PM growth 3Y-2.84%
PM growth 5Y4.67%
GM growth 3Y-4.58%
GM growth 5Y-0.69%
F-Score5
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.28
Debt/EBITDA 3.46
Cap/Depr 168.85%
Cap/Sales 0.93%
Interest Coverage 507.7
Cash Conversion 114.36%
Profit Quality 130.01%
Current Ratio 7.7
Quick Ratio 2.69
Altman-Z 3.68
F-Score5
WACC9.28%
ROIC/WACC0.73
Cap/Depr(3y)122.4%
Cap/Depr(5y)114.53%
Cap/Sales(3y)0.67%
Cap/Sales(5y)0.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.16%
EPS 3Y0.91%
EPS 5Y10.85%
EPS Q2Q%44.44%
EPS Next Y-1.74%
EPS Next 2Y2.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.8%
Revenue growth 3Y5.97%
Revenue growth 5Y8.66%
Sales Q2Q%-11.39%
Revenue Next Year6.2%
Revenue Next 2Y7.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.03%
EBIT growth 3Y0.19%
EBIT growth 5Y10.54%
EBIT Next Year47.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.98%
OCF growth 3YN/A
OCF growth 5YN/A

M D C Holdings Inc / MDC FAQ

What is the ChartMill fundamental rating of M D C Holdings Inc (MDC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MDC.


What is the valuation status for MDC stock?

ChartMill assigns a valuation rating of 5 / 10 to M D C Holdings Inc (MDC). This can be considered as Fairly Valued.


Can you provide the profitability details for M D C Holdings Inc?

M D C Holdings Inc (MDC) has a profitability rating of 6 / 10.


How financially healthy is M D C Holdings Inc?

The financial health rating of M D C Holdings Inc (MDC) is 6 / 10.


What is the expected EPS growth for M D C Holdings Inc (MDC) stock?

The Earnings per Share (EPS) of M D C Holdings Inc (MDC) is expected to decline by -1.74% in the next year.